MAP3K5 (Ab-966) Antibody

Shipped with Ice Packs
In Stock

Product Specs

Form
Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Lead Time
Typically, we can ship the products within 1-3 business days of receiving your order. Delivery times may vary depending on the purchasing method or location. Please consult your local distributor for specific delivery time estimates.
Synonyms
Apoptosis signal regulating kinase 1 antibody; Apoptosis signal-regulating kinase 1 antibody; ASK 1 antibody; ASK-1 antibody; ASK1 antibody; M3K5 antibody; M3K5_HUMAN antibody; MAP/ERK kinase kinase 5 antibody; MAP3K5 antibody; MAPK/ERK kinase kinase 5 antibody; MAPKKK5 antibody; MEK kinase 5 antibody; MEKK 5 antibody; MEKK5 antibody; Mitogen activated protein kinase kinase kinase 5 antibody; Mitogen-activated protein kinase kinase kinase 5 antibody
Target Names
Uniprot No.

Target Background

Function
MAP3K5/ASK1 is a serine/threonine kinase that plays a crucial role in the MAP kinase signal transduction pathway. It acts as an essential component of the pathway, mediating cellular responses to environmental changes. ASK1 is involved in determining cell fate, including differentiation and survival, and plays a significant role in the apoptotic signal transduction pathway through mitochondria-dependent caspase activation. ASK1 is essential for the innate immune response, providing defense against a wide range of pathogens. It mediates signal transduction of various stressors, such as oxidative stress, and receptor-mediated inflammatory signals, including tumor necrosis factor (TNF) and lipopolysaccharide (LPS). Upon activation, ASK1 acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade, achieved through the phosphorylation and activation of several MAP kinase kinases (MAP2Ks), including MAP2K4/SEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks, in turn, activate p38 MAPKs and c-jun N-terminal kinases (JNKs). Both p38 MAPK and JNKs control the transcription factors activator protein-1 (AP-1).
Gene References Into Functions
  • Advanced glycation end products significantly activate ASK1, MKK3, and MKK6, leading to p38 MAPK activation and ultimately an upregulated fibrotic response in human coronary smooth muscle cells. PMID: 30305582
  • ASK1 transcriptional upregulation defines a metabolically-detrimental obese sub-phenotype. PMID: 28702328
  • Knockdown of miR-20a enhances the sensitivity of colorectal cancer cells to cisplatin through the ROS/ASK1/JNK pathway. PMID: 29940575
  • These findings provide insight into the positive regulation of Akt signaling through P2Y12 phosphorylation, as well as MAPK signaling in platelets by ASK1. PMID: 28753204
  • Cold stress-induced ferroptosis involves the ASK1-p38 pathway. PMID: 28887319
  • TRIM48 promotes ASK1 activation and cell death through ubiquitination-dependent degradation of the ASK1-negative regulator PRMT1. PMID: 29186683
  • These findings indicate that chaetocin arrests the cell cycle and induces apoptosis by regulating the reactive oxygen species-mediated ASK-1/JNK signaling pathways. PMID: 28849240
  • Findings provide evidence that ASK-1 expression is regulated by SLC35F2, which exerts its oncogenic effect on papillary thyroid carcinoma progression through activation of TGFBR-1 and ASK-1. PMID: 29274137
  • Co-administration of acetaminophen and 5'-AMP significantly ameliorated APAP-induced hepatotoxicity in mice. This was triggered by attenuating apoptosis signal-regulated kinase 1 (ASK1) methylation and increasing ubiquitination-mediated ASK1 protein degradation. PMID: 28031524
  • The anti-cancer mechanism of AgNPs may involve activating the ASK1-JNK/p38-Caspase-3 pathway. PMID: 29381295
  • TRAF1 functions as a positive regulator of insulin resistance, inflammation, and hepatic steatosis dependent on the activation of the ASK1-P38/JNK axis. PMID: 26860405
  • LRRK2-induced apoptosis was suppressed by ASK1 inhibition in neuronal stem cells derived from patients with Parkinson's disease (PD). These results indicate that LRRK2 acts as an upstream kinase in the ASK1 pathway and plays an important role in the pathogenesis of PD. PMID: 28888991
  • Apoptosis signal-regulating kinase 1 (ASK1) expression was dramatically suppressed and correlated with hepatocyte nuclear factor 4alpha (HNF4alpha) levels in hepatocellular carcinoma (HCC) tissues. PMID: 27050273
  • ASK1 phosphorylated and stabilized TLX, which led to the induction of HIF-1alpha, and its downstream VEGF-A in an Akt-dependent manner. PMID: 27890558
  • CD40 activation resulted in the down-regulation of Thioredoxin (Trx)-1 to permit ASK1 activation and apoptosis. While soluble receptor agonist alone could not induce death, combinatorial treatment incorporating soluble CD40 agonist and pharmacological inhibition of Trx-1 was functionally equivalent to the signal triggered by mCD40L. PMID: 27869172
  • These results suggest that platelet Ask1 plays an important role in the regulation of hemostasis and thrombosis. PMID: 28028021
  • Of the two catalytic cysteines of TRX1, the residue C32 is responsible for the high-affinity binding of TRX1 to the ASK1-TRX-binding domain in reducing conditions. PMID: 27588831
  • Shotgun mass spectrometry and manual validation identified 12 distinct ASK1 phosphosites. Targeted parallel reaction monitoring assays were used to track the phosphorylation dynamics of each confirmed site in response to treatment. PMID: 27989136
  • Phosphorus NMR and time-resolved tryptophan fluorescence measurements suggest that 14-3-3zeta interacts with the kinase domain of ASK1 in close proximity to its active site. This interaction might block accessibility and/or affect its conformation. PMID: 27514745
  • The ASK1 MAP kinase signaling cascade is an important regulator of chondrocyte terminal differentiation. PMID: 26405834
  • Pretreatment with IRE1 agonist tunicamycin or JNK agonist anisomycin attenuated the effect of psoralen on osteoporotic osteoblasts. Psoralen inhibited apoptosis of osteoporotic osteoblasts by regulating the IRE1-ASK1-JNK pathway. PMID: 28349059
  • Our results suggest that GSK-3beta is a key factor involved in ASK1 activation and reactive oxygen species-induced cell death. PMID: 27221474
  • The data shows that miRNA-mediated down-regulation of ASK1 protects mesenchymal stem cells during post-transplantation, leading to increased efficacy of MSC-based cell therapy. PMID: 27775615
  • Cross-talk between arginine methylation and serine phosphorylation in ASK1. PRMT5 is an ASK1-binding protein and mediates arginine methylation of ASK1. PMID: 26912789
  • Results suggest that baicalein-mediated ASK1/JNK activation regulates the mitochondria-dependent apoptosis pathway through the up-regulation of TAp63 and down-regulation of NF-kappaB and CD74/CD44 in B-cell malignancies. PMID: 26694167
  • The effect of curcumin and ABT-737 on HCC cells was investigated for the first time. Curcumin markedly enhanced the antitumor effects of ABT-737 on HepG2 cells and activated the ROS-ASK1-c-Jun N-terminal kinase pathway. PMID: 26707143
  • ASK1 signaling regulates brown and beige adipocyte function. PMID: 27045525
  • These results implicate the TNF/TRAF2/ASK1/p38 kinase pathway in modulating the risk of pulmonary complications. PMID: 26165383
  • The present findings support the notion that ROR1 sustains lung adenocarcinoma survival, at least in part, through direct physical interaction with ASK1. PMID: 26661061
  • Together, we suggest that 4SC-202 activates the ASK1-dependent mitochondrial apoptosis pathway to potently inhibit human HCC cells. PMID: 26773495
  • Data shows that the MAPKKK6 ASK2, a modulator of MAPKKK5 ASK1 signaling, was essential for ASK1-dependent apoptosis, but not for inducing interferon-beta (IFNB) expression. PMID: 26243192
  • The expression of ASK1 is correlated with the level of claudin-6 in cervical carcinoma cells and tissues. PMID: 26191261
  • ASK1 stabilizes APOBEC3G and binds HIV-1 Vif, disrupting the assembly of the Vif-ubiquitin ligase complex, thus restoring the antiviral activity of APOBEC3g. PMID: 25901786
  • Data indicates that ASK1 expression is regulated by MiR-19a by targeting specific sites in the 3' untranslated region of its mRNA. PMID: 25982447
  • Findings suggest that methyl isocyanate inhibits angiogenesis by inducing mitogen-activated protein kinase kinase kinase 5 ASK1-JNK-dependent endothelial cell death. PMID: 25068797
  • TNF-alpha-induced ASK1-p38/JNK pathway is an important mediator of cytokine synthesis and enhanced expression of adhesion molecules in rheumatoid arthritis and is inhibited by thymoquinone. PMID: 26134265
  • Cyclophilin A regulates JNK/p38-MAPK signaling through its physical interaction with ASK1. PMID: 26095851
  • Knockdown of IRE1alpha by siRNA dramatically abrogated CXC195-induced activation of TRAF2, ASK and JNK, formation of an IRE1alpha-TRAF2-ASK1 complex and caspase- and mitochondrial-dependent apoptosis in T24 cells. PMID: 25797626
  • Because the phosphorylation site mutants of NR4A2 cannot rescue the cell death-promoting activity, ASK1-p38 pathway-dependent phosphorylation and subsequent cytoplasmic translocation of NR4A2 may be required for oxidative stress-induced cell death. PMID: 25752609
  • Collectively, these data reveal that activation of the PI3K/Akt pathway limits JNK-mediated apoptosis by phosphorylating and inactivating ASK1 during human enterovirus 71 infection. PMID: 25116390
  • Siah1 is a substrate of ASK1 for activation of the GAPDH-Siah1 oxidative stress signaling cascade. PMID: 25391652
  • TNF-signaling dependence of ASK1-mediated apoptosis in melanoma cells. PMID: 24574456
  • Data show that ASK1 is critical for IFN gamma-induced DAPK1 via ATF6 recruitment. PMID: 25135476
  • Apoptosis signal-regulating kinase 1 has a role in chondrosarcoma cell apoptosis along with endoplasmic reticulum stress due to FPipTB. PMID: 21594902
  • Data suggest that degradation of ASK1 mediated by Roquin-2 is an evolutionarily conserved mechanism required for the appropriate regulation of stress responses, including pathogen resistance and cell death. PMID: 24448648
  • It is activated in response to various stresses, such as reactive oxygen species (ROS) and endoplasmic reticulum (ER) stress, and plays pivotal roles in a wide variety of cellular responses, including cell death, differentiation and inflammation. (review) PMID: 24912301
  • Data indicate that the ASK1-FoxO3a-TRADD-caspase 8 pathway is present in neural tube defects (NTDs)-affected tissues. PMID: 23982205
  • MAP3K5 R256C mutation revealed attenuation of MKK4 activation through increased binding of the inhibitory protein thioredoxin (TXN/TRX-1/Trx), resulting in increased proliferation and anchorage-independent growth of melanoma cells. PMID: 24008424
  • Identification of the domain through which HIV-1 Nef interacts with ASK1 and inhibits its function. PMID: 23799149
  • In gastric epithelial cells, H. pylori activates ASK1 in a reactive oxygen species - and cag pathogenicity island-dependent manner, and ASK1 regulates sustained JNK activation and apoptosis induced by H. pylori. PMID: 24082073

Show More

Hide All

Database Links

HGNC: 6857

OMIM: 602448

KEGG: hsa:4217

STRING: 9606.ENSP00000351908

UniGene: Hs.186486

Protein Families
Protein kinase superfamily, STE Ser/Thr protein kinase family, MAP kinase kinase kinase subfamily
Subcellular Location
Cytoplasm. Endoplasmic reticulum. Note=Interaction with 14-3-3 proteins alters the distribution of MAP3K5/ASK1 and restricts it to the perinuclear endoplasmic reticulum region.
Tissue Specificity
Abundantly expressed in heart and pancreas.

Q&A

What is MAP3K5 (Ab-966) Antibody and what epitope does it recognize?

MAP3K5 (Ab-966) antibody is a rabbit polyclonal antibody specifically designed to recognize the phosphorylation site at Serine 966 of human Apoptosis Signal-regulating Kinase 1 (ASK1), also known as Mitogen-activated protein kinase kinase kinase 5 (MAP3K5). The antibody is generated using a synthesized peptide derived from the region surrounding amino acids 964-968 (S-I-S-L-P) of human ASK1 .

The epitope recognition is specific to the phosphorylated form of this serine residue, making this antibody particularly useful for studying the regulatory mechanisms of ASK1 through this specific post-translational modification.

What is the functional significance of MAP3K5/ASK1 in cellular signaling?

MAP3K5/ASK1 functions as an essential component of the MAP kinase signal transduction cascade. It plays crucial roles in:

  • Mediating cellular responses to environmental changes

  • Signal transduction for cell fate determination including differentiation and survival

  • Apoptosis signal transduction through mitochondria-dependent caspase activation

  • Innate immune response essential for host defense against pathogens

  • Stress response signaling, particularly oxidative stress

  • Receptor-mediated inflammatory signal transduction (e.g., TNF, LPS)

When activated, MAP3K5/ASK1 functions as an upstream activator of MKK/JNK and p38 MAPK signaling cascades by phosphorylating and activating several MAP kinase kinases including MAP2K4/SEK1, MAP2K3/MKK3, MAP2K6/MKK6, and MAP2K7/MKK7 .

What applications has the MAP3K5 (Ab-966) Antibody been validated for?

According to multiple sources, the MAP3K5 (Ab-966) antibody has been validated for the following applications:

ApplicationRecommended DilutionNotes
Western Blotting (WB)1:500-1:2000Verified with 293 cell samples
Immunohistochemistry (IHC-p)1:50-1:300Paraffin-embedded sections
Immunofluorescence (IF)1:100-1:200For cellular localization studies
ELISAAs recommended by manufacturerFor quantitative detection

The antibody has been specifically verified in Western blotting applications using 293 cell lysates .

What is the species reactivity profile of the MAP3K5 (Ab-966) Antibody?

The MAP3K5 (Ab-966) antibody has been confirmed to react with:

  • Human

  • Mouse

  • Rat

This cross-species reactivity makes it valuable for comparative studies across different model systems .

What is the proper storage and handling protocol for MAP3K5 (Ab-966) Antibody?

For optimal antibody performance and longevity:

  • Store at -20°C or -80°C upon receipt for long-term storage

  • For frequent use and short-term storage (up to one month), the antibody can be kept at 4°C

  • Avoid repeated freeze-thaw cycles

  • The antibody is typically supplied in phosphate buffered saline (without Mg²⁺ and Ca²⁺), pH 7.4, containing 150mM NaCl, 0.02% sodium azide, and 50% glycerol

  • Most formulations include stabilizers like 0.05% stabilizer and 0.5% protein protectant

How does phosphorylation at Ser966 mechanistically regulate MAP3K5/ASK1 activity?

Phosphorylation at Ser966 represents a key regulatory mechanism for MAP3K5/ASK1 activity. This specific modification occurs in response to various cellular stressors and affects protein-protein interactions critical for MAP3K5 function.

When Ser966 is phosphorylated, it promotes interaction with 14-3-3 proteins, which alters the subcellular distribution of MAP3K5/ASK1, restricting it to the perinuclear endoplasmic reticulum region. This sequestration effectively inhibits its kinase activity by preventing interaction with downstream targets .

In contrast to activating phosphorylation sites, Ser966 phosphorylation serves as an inhibitory modification that helps maintain MAP3K5/ASK1 in an inactive state under normal conditions. Understanding the balance between activating and inhibitory phosphorylation is crucial for interpreting experimental results.

What experimental conditions optimize detection of Ser966 phosphorylation?

To effectively detect Ser966 phosphorylation of MAP3K5/ASK1:

  • Cell stimulation conditions:

    • For basal phosphorylation: Serum-starve cells for 4-6 hours before harvesting

    • For induced dephosphorylation: Treat cells with oxidative stress inducers (H₂O₂, 0.5-1 mM for 15-30 minutes)

    • For increased phosphorylation: Growth factor stimulation (serum, EGF, or insulin)

  • Lysis buffer composition:

    • Include phosphatase inhibitors (sodium fluoride, sodium orthovanadate, β-glycerophosphate)

    • Add protease inhibitors cocktail

    • Use RIPA or NP-40 based buffers with 1% detergent concentration

  • Sample preparation:

    • Maintain cold temperatures throughout processing

    • Process samples quickly to minimize phosphatase activity

    • Load adequate protein amount (typically 30-50 μg per lane for cell lysates)

    • For tissue samples, rapid freezing in liquid nitrogen followed by homogenization in cold lysis buffer is recommended

What are the most effective experimental controls when working with MAP3K5 (Ab-966) Antibody?

A robust experimental design when working with MAP3K5 (Ab-966) antibody should include:

Positive controls:

  • 293 cell lysates (verified as a positive control in manufacturer validation)

  • Heart or pancreas tissue lysates (where MAP3K5 is abundantly expressed)

  • Cells treated with known activators of the ASK1 pathway

Negative controls:

  • MAP3K5/ASK1 knockdown or knockout samples

  • Competing peptide blocking experiments

  • Samples treated with lambda phosphatase to remove phosphorylation

Specificity controls:

  • Parallel blots with antibodies detecting total MAP3K5/ASK1

  • Comparison with antibodies targeting other phosphorylation sites on MAP3K5/ASK1

  • Dephosphorylation assays to confirm phospho-specificity

How can I troubleshoot inconsistent results when using MAP3K5 (Ab-966) Antibody in Western blotting?

When encountering inconsistent results with the MAP3K5 (Ab-966) antibody in Western blotting applications:

IssuePotential CauseSolution
No signalInsufficient protein loadingIncrease protein concentration (load 50-70 μg)
Phosphatase activity during preparationEnsure proper phosphatase inhibitors are present
Improper transferOptimize transfer conditions for high MW proteins (≈155 kDa)
Multiple bandsDifferent modified forms of MAP3K5Expected; MAP3K5 can have multiple phosphorylation sites
Non-specific bindingIncrease blocking time/concentration; optimize antibody dilution
Incorrect molecular weightPost-translational modificationsExpected; phosphorylation can alter migration
Proteolytic degradationAdd protease inhibitors during sample preparation
Weak signalLow expression levelsEnrich for phosphorylated proteins via immunoprecipitation
Suboptimal detection methodConsider switching to more sensitive detection systems

Always verify the expected molecular weight of MAP3K5/ASK1, which is calculated to be approximately 155 kDa .

What considerations are important for detecting MAP3K5 Ser966 phosphorylation in tissue samples?

Detecting MAP3K5 Ser966 phosphorylation in tissue samples requires special considerations:

  • Tissue preparation:

    • Rapid fixation is critical to preserve phosphorylation status

    • For frozen sections, snap-freeze tissues immediately in liquid nitrogen

    • For FFPE samples, use 10% neutral buffered formalin with fixation time not exceeding 24 hours

  • Antigen retrieval optimization:

    • Test both heat-mediated (citrate buffer, pH 6.0) and enzymatic methods

    • For phospho-epitopes, EDTA-based retrieval (pH 9.0) often yields better results

    • Carefully monitor retrieval times to prevent epitope destruction

  • Signal amplification:

    • Consider using tyramide signal amplification for low abundance phosphoproteins

    • Polymer detection systems often provide better sensitivity than traditional ABC methods

  • Tissue-specific considerations:

    • Heart and pancreas tissues show abundant expression of MAP3K5/ASK1

    • Control for endogenous peroxidase activity, particularly in blood-rich tissues

    • Include proper positive controls from the same tissue type

How can MAP3K5 (Ab-966) Antibody be effectively used in studying stress-response pathways?

To effectively use MAP3K5 (Ab-966) antibody in stress-response pathway studies:

  • Experimental design for pathway analysis:

    • Time-course experiments: Monitor Ser966 phosphorylation changes over time (0, 5, 15, 30, 60 min) following stress induction

    • Dose-response studies: Vary concentrations of stress inducers to determine threshold for Ser966 phosphorylation changes

    • Combinatorial stress experiments: Apply multiple stressors to evaluate interaction effects

  • Relevant stress inducers for MAP3K5/ASK1 studies:

    • Oxidative stress: H₂O₂ (0.5-1 mM), paraquat, menadione

    • Inflammatory stimuli: TNFα (10-50 ng/ml), IL-1β, LPS

    • ER stress: tunicamycin, thapsigargin

    • Genotoxic stress: UV irradiation, etoposide

  • Pathway validation approaches:

    • Pharmacological inhibitors: p38 MAPK inhibitors (SB203580), JNK inhibitors (SP600125)

    • Genetic manipulation: siRNA/shRNA against upstream regulators or downstream effectors

    • Correlation with downstream markers: monitor phosphorylation of p38 MAPK and JNK in parallel

  • Integration with other techniques:

    • Combine with cell viability/apoptosis assays to correlate phosphorylation with functional outcomes

    • Utilize subcellular fractionation to track MAP3K5/ASK1 localization changes upon stress

    • Employ proximity ligation assays to detect stress-induced protein interactions (e.g., with 14-3-3 proteins)

What methodological approaches can help distinguish between different phosphorylation states of MAP3K5/ASK1?

MAP3K5/ASK1 contains multiple phosphorylation sites that regulate its activity in complex ways. To distinguish between different phosphorylation states:

  • Multi-antibody approach:

    • Use a panel of phospho-specific antibodies targeting different sites (S83, S966, T838, etc.)

    • Compare with total MAP3K5/ASK1 antibody to determine phosphorylation stoichiometry

    • Run parallel Western blots or use different fluorescent secondary antibodies for multiplexing

  • Phosphatase treatment controls:

    • Lambda phosphatase: Removes all phosphorylation

    • Serine/threonine-specific phosphatases: Can help distinguish between phospho-serine and phospho-threonine

  • Mass spectrometry-based approaches:

    • Immunoprecipitate MAP3K5/ASK1 and perform phosphopeptide mapping

    • Use MRM (Multiple Reaction Monitoring) for quantitative analysis of specific phosphorylation sites

    • Consider SILAC or TMT labeling for comparing phosphorylation across conditions

  • Phospho-mimetic and phospho-dead mutants:

    • Generate S966A (phospho-dead) and S966D/E (phospho-mimetic) mutants

    • Use these mutants as controls for antibody specificity and to study functional consequences

  • 2D gel electrophoresis:

    • Different phosphorylation states will appear as distinct spots

    • Can be followed by Western blotting with MAP3K5 (Ab-966) antibody

How can I integrate MAP3K5 (Ab-966) Antibody analysis with functional assays of ASK1 activity?

For comprehensive studies integrating MAP3K5 Ser966 phosphorylation status with functional activity:

  • Kinase activity assays:

    • In vitro kinase assays using immunoprecipitated MAP3K5/ASK1 and substrates like MKK4 or MKK6

    • Correlation of Ser966 phosphorylation status with kinase activity

    • ATP consumption assays as surrogate measures of kinase activity

  • Downstream pathway activation:

    • Monitor phosphorylation of direct MAP3K5 substrates (MAP2K4/MAP2K6)

    • Assess activation of downstream MAPKs (p38, JNK)

    • Evaluate transcriptional changes of known target genes

  • Cellular outcome measurements:

    • Apoptosis assays: Annexin V/PI staining, caspase activity, TUNEL assay

    • Cell cycle analysis to detect stress-induced cell cycle arrest

    • ROS measurement to correlate oxidative stress with Ser966 phosphorylation

  • Co-immunoprecipitation studies:

    • Investigate how Ser966 phosphorylation affects protein-protein interactions

    • Focus on known interaction partners like 14-3-3 proteins, TRAF2, TRAF6

    • Combine with proximity ligation assays for in situ interaction detection

  • Translocation analyses:

    • Track subcellular localization changes using fractionation followed by Western blotting

    • Immunofluorescence microscopy to visualize relocalization between cytoplasm and endoplasmic reticulum

    • Live-cell imaging with fluorescently tagged MAP3K5/ASK1 to monitor dynamic changes

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.